tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 245 are a BUY (76.32%), 76 are a HOLD (23.68%).
Analyst Joseph Catanzaro, carries an average stock price target met ratio of 42.69% that have a potential upside of 41.76% achieved within 146 days. Previously, Joseph Catanzaro worked at PIPER SANDLER.
Joseph Catanzaro’s has documented 618 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on IBRX, Immunitybio at 20-May-2025.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for CTMX (CYTOMX THERAPEUTICS) at 4/14/2025. The price target of $2.5 was fulfilled within 29 days with a profit of $1.89 (309.84%) receiving and performance score of 106.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.75
$-0.27 (-13.37%)
$5
1 years 1 months 26 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold
1 years 2 months 2 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Buy
1 years 10 months 8 days ago
(15-Dec-2023)
0/1 (0%)
$20.97 (87.27%)
Buy
3 years 6 months 12 days ago
(11-Apr-2022)
0/1 (0%)
$93 (163.16%)
Buy
3 years 6 months 12 days ago
(11-Apr-2022)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
